Bogart Wealth LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65K Buy
11
+3
+38% +$657 ﹤0.01% 1384
2026
Q1
$1.51K Sell
8
-542
-99% -$94.7K ﹤0.01% 1335
2025
Q4
$93.5K Buy
550
+546
+13,650% +$83.7K ﹤0.01% 349
2025
Q3
$527 Hold
4
– – ﹤0.01% 1411
2025
Q2
$424 Hold
4
– – ﹤0.01% 1377
2025
Q1
$497 Buy
+4
New +$522 ﹤0.01% 1282

Other funds holding JAZZ

Bogart Wealth LLC's JAZZ Position: Q2 2026 in Review

Bogart Wealth LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 38% in Q2 2026, buying an estimated $657 and bringing the position to 11 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Bogart Wealth LLC first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $93.5K in Q4 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Bogart Wealth LLC held 11 shares of Jazz Pharmaceuticals worth $2.65K as of Q2 2026.
  • Bogart Wealth LLC bought 3 Jazz Pharmaceuticals shares in Q2 2026, an estimated $657.
  • Jazz Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1384 holding.
  • Bogart Wealth LLC first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Bogart Wealth LLC's Jazz Pharmaceuticals position peaked at $93.5K in Q4 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.